Structure

Physi-Chem Properties

Molecular Weight:  364.15
Volume:  365.78
LogP:  2.147
LogD:  2.257
LogS:  -3.459
# Rotatable Bonds:  1
TPSA:  116.45
# H-Bond Aceptor:  7
# H-Bond Donor:  4
# Rings:  2
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.439
Synthetic Accessibility Score:  4.533
Fsp3:  0.421
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.098
MDCK Permeability:  1.921649709402118e-05
Pgp-inhibitor:  0.002
Pgp-substrate:  0.02
Human Intestinal Absorption (HIA):  0.509
20% Bioavailability (F20%):  0.019
30% Bioavailability (F30%):  0.993

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.329
Plasma Protein Binding (PPB):  97.8525161743164%
Volume Distribution (VD):  0.833
Pgp-substrate:  4.878355026245117%

ADMET: Metabolism

CYP1A2-inhibitor:  0.244
CYP1A2-substrate:  0.222
CYP2C19-inhibitor:  0.034
CYP2C19-substrate:  0.253
CYP2C9-inhibitor:  0.035
CYP2C9-substrate:  0.938
CYP2D6-inhibitor:  0.41
CYP2D6-substrate:  0.791
CYP3A4-inhibitor:  0.106
CYP3A4-substrate:  0.105

ADMET: Excretion

Clearance (CL):  8.759
Half-life (T1/2):  0.84

ADMET: Toxicity

hERG Blockers:  0.041
Human Hepatotoxicity (H-HT):  0.533
Drug-inuced Liver Injury (DILI):  0.116
AMES Toxicity:  0.008
Rat Oral Acute Toxicity:  0.018
Maximum Recommended Daily Dose:  0.947
Skin Sensitization:  0.706
Carcinogencity:  0.697
Eye Corrosion:  0.004
Eye Irritation:  0.122
Respiratory Toxicity:  0.811

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC277426

Natural Product ID:  NPC277426
Common Name*:   Zeaenol
IUPAC Name:   (2E,5S,6S,7S,8E,11S)-5,6,7,15-tetrahydroxy-17-methoxy-11-methyl-12-oxabicyclo[12.4.0]octadeca-1(14),2,8,15,17-pentaen-13-one
Synonyms:   Zeaenol
Standard InCHIKey:  BPOLRDGTYHVUAY-YMFWJEOZSA-N
Standard InCHI:  InChI=1S/C19H24O7/c1-11-5-3-7-14(20)18(23)15(21)8-4-6-12-9-13(25-2)10-16(22)17(12)19(24)26-11/h3-4,6-7,9-11,14-15,18,20-23H,5,8H2,1-2H3/b6-4+,7-3+/t11-,14-,15-,18+/m0/s1
SMILES:  C[C@H]1C/C=C/[C@@H]([C@H]([C@H](C/C=C/c2cc(cc(c2C(=O)O1)O)OC)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1099228
PubChem CID:   46888372
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000147] Macrolides and analogues

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33425 paecilomyces fungus Species n.a. Eukaryota n.a. n.a. n.a. PMID[20429578]
NPO30448 Cochliobolus lunatus Species Pleosporaceae Eukaryota n.a. n.a. n.a. PMID[21348465]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT83 Cell Line MCF7 Homo sapiens IC50 > 100000.0 nM PMID[545290]
NPT397 Cell Line NCI-H460 Homo sapiens IC50 > 100000.0 nM PMID[545290]
NPT395 Cell Line SF-268 Homo sapiens IC50 > 100000.0 nM PMID[545290]
NPT139 Cell Line HT-29 Homo sapiens IC50 > 25000.0 nM PMID[545290]
NPT400 Cell Line MDA-MB-435 Homo sapiens IC50 > 25000.0 nM PMID[545290]
NPT3442 Individual Protein Mitogen-activated protein kinase kinase kinase 7 Homo sapiens IC50 = 10000.0 nM PMID[545292]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 > 50000.0 nM PMID[545289]
NPT721 Individual Protein Nuclear factor NF-kappa-B p65 subunit Homo sapiens IC50 > 50000.0 nM PMID[545290]
NPT19 Organism Escherichia coli Escherichia coli MIC > 500.0 ug.mL-1 PMID[545290]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC > 500.0 ug.mL-1 PMID[545290]
NPT602 Organism Mycobacterium smegmatis Mycobacterium smegmatis MIC > 500.0 ug.mL-1 PMID[545290]
NPT79 Organism Bacillus subtilis Bacillus subtilis MIC > 500.0 ug.mL-1 PMID[545290]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC277426 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC86373
1.0 High Similarity NPC210425
1.0 High Similarity NPC280404
0.9854 High Similarity NPC474385
0.9786 High Similarity NPC210320
0.9716 High Similarity NPC215711
0.9716 High Similarity NPC73411
0.9708 High Similarity NPC158472
0.964 High Similarity NPC51106
0.9638 High Similarity NPC67650
0.9638 High Similarity NPC475730
0.9638 High Similarity NPC1704
0.958 High Similarity NPC469619
0.958 High Similarity NPC469670
0.9514 High Similarity NPC240768
0.9514 High Similarity NPC70016
0.9514 High Similarity NPC215921
0.9514 High Similarity NPC200773
0.9507 High Similarity NPC472036
0.9504 High Similarity NPC472034
0.95 High Similarity NPC469542
0.95 High Similarity NPC472006
0.9496 High Similarity NPC158634
0.9489 High Similarity NPC135837
0.9437 High Similarity NPC472033
0.9429 High Similarity NPC469579
0.942 High Similarity NPC94248
0.942 High Similarity NPC212693
0.942 High Similarity NPC33144
0.942 High Similarity NPC478200
0.9375 High Similarity NPC476684
0.9375 High Similarity NPC270160
0.9375 High Similarity NPC237440
0.9366 High Similarity NPC83272
0.9353 High Similarity NPC32360
0.9348 High Similarity NPC70380
0.9343 High Similarity NPC180905
0.9343 High Similarity NPC182496
0.932 High Similarity NPC99381
0.9306 High Similarity NPC240622
0.9306 High Similarity NPC240253
0.9306 High Similarity NPC471642
0.9306 High Similarity NPC471641
0.9301 High Similarity NPC107625
0.9291 High Similarity NPC250755
0.9281 High Similarity NPC191835
0.922 High Similarity NPC478217
0.922 High Similarity NPC478201
0.922 High Similarity NPC90411
0.922 High Similarity NPC313123
0.922 High Similarity NPC472035
0.9214 High Similarity NPC139634
0.9214 High Similarity NPC268052
0.9214 High Similarity NPC247409
0.9214 High Similarity NPC105456
0.9209 High Similarity NPC71256
0.9197 High Similarity NPC153783
0.9189 High Similarity NPC16082
0.9189 High Similarity NPC82592
0.9184 High Similarity NPC167903
0.9178 High Similarity NPC179178
0.9167 High Similarity NPC473023
0.9161 High Similarity NPC95123
0.9161 High Similarity NPC66404
0.9143 High Similarity NPC472602
0.9137 High Similarity NPC235115
0.9122 High Similarity NPC281477
0.9097 High Similarity NPC134621
0.9097 High Similarity NPC257558
0.9097 High Similarity NPC312789
0.9091 High Similarity NPC478202
0.9085 High Similarity NPC472605
0.9085 High Similarity NPC244923
0.9085 High Similarity NPC472604
0.9085 High Similarity NPC53649
0.9067 High Similarity NPC246466
0.9067 High Similarity NPC190020
0.9067 High Similarity NPC84935
0.9067 High Similarity NPC77679
0.906 High Similarity NPC79998
0.9054 High Similarity NPC478224
0.9051 High Similarity NPC219892
0.9051 High Similarity NPC189823
0.9048 High Similarity NPC56204
0.9048 High Similarity NPC96501
0.9048 High Similarity NPC472891
0.9034 High Similarity NPC237208
0.9034 High Similarity NPC225173
0.9034 High Similarity NPC163846
0.9028 High Similarity NPC210966
0.9028 High Similarity NPC151607
0.9028 High Similarity NPC42540
0.9028 High Similarity NPC478203
0.9028 High Similarity NPC126882
0.9021 High Similarity NPC96692
0.9021 High Similarity NPC82913
0.9021 High Similarity NPC105648
0.9014 High Similarity NPC472601
0.9014 High Similarity NPC165172
0.9014 High Similarity NPC472600
0.9007 High Similarity NPC9121
0.9007 High Similarity NPC177307
0.9007 High Similarity NPC475974
0.9007 High Similarity NPC470339
0.9 High Similarity NPC472050
0.9 High Similarity NPC150227
0.9 High Similarity NPC227062
0.8993 High Similarity NPC175943
0.898 High Similarity NPC77325
0.898 High Similarity NPC4423
0.8973 High Similarity NPC14098
0.8973 High Similarity NPC8817
0.8973 High Similarity NPC125801
0.8966 High Similarity NPC29577
0.8958 High Similarity NPC471731
0.8958 High Similarity NPC159721
0.8951 High Similarity NPC220106
0.8951 High Similarity NPC472603
0.8947 High Similarity NPC472055
0.8944 High Similarity NPC52358
0.8936 High Similarity NPC178467
0.8936 High Similarity NPC474771
0.8936 High Similarity NPC474849
0.8936 High Similarity NPC65837
0.8936 High Similarity NPC194579
0.8936 High Similarity NPC149372
0.8933 High Similarity NPC199926
0.8933 High Similarity NPC208173
0.8933 High Similarity NPC69043
0.8933 High Similarity NPC170189
0.8933 High Similarity NPC478230
0.8929 High Similarity NPC142027
0.8926 High Similarity NPC76041
0.8926 High Similarity NPC273483
0.8926 High Similarity NPC115249
0.8926 High Similarity NPC184284
0.8919 High Similarity NPC475460
0.8912 High Similarity NPC37139
0.8912 High Similarity NPC153417
0.8904 High Similarity NPC260946
0.8904 High Similarity NPC470357
0.8904 High Similarity NPC138978
0.8897 High Similarity NPC470932
0.8889 High Similarity NPC471733
0.8889 High Similarity NPC471640
0.8889 High Similarity NPC49108
0.8889 High Similarity NPC471644
0.8881 High Similarity NPC155205
0.8873 High Similarity NPC126739
0.8873 High Similarity NPC472403
0.8873 High Similarity NPC197666
0.8867 High Similarity NPC137301
0.8859 High Similarity NPC46882
0.8859 High Similarity NPC132990
0.8859 High Similarity NPC204350
0.8851 High Similarity NPC291049
0.8851 High Similarity NPC233267
0.8849 High Similarity NPC470160
0.8844 High Similarity NPC166583
0.8844 High Similarity NPC53362
0.8844 High Similarity NPC137296
0.8844 High Similarity NPC12305
0.8841 High Similarity NPC42292
0.8841 High Similarity NPC307732
0.8836 High Similarity NPC473692
0.8836 High Similarity NPC75694
0.8832 High Similarity NPC293453
0.8828 High Similarity NPC472610
0.8828 High Similarity NPC471643
0.8828 High Similarity NPC471639
0.8819 High Similarity NPC130485
0.8816 High Similarity NPC472889
0.8816 High Similarity NPC473395
0.8811 High Similarity NPC92655
0.8811 High Similarity NPC88269
0.8811 High Similarity NPC471819
0.8811 High Similarity NPC474655
0.8808 High Similarity NPC67396
0.8808 High Similarity NPC472890
0.8803 High Similarity NPC472364
0.8803 High Similarity NPC476333
0.8803 High Similarity NPC470397
0.8803 High Similarity NPC472367
0.8803 High Similarity NPC473391
0.88 High Similarity NPC470340
0.88 High Similarity NPC268992
0.88 High Similarity NPC295646
0.88 High Similarity NPC470337
0.88 High Similarity NPC51824
0.88 High Similarity NPC474843
0.88 High Similarity NPC470338
0.88 High Similarity NPC113608
0.8794 High Similarity NPC27407
0.8792 High Similarity NPC60413
0.8792 High Similarity NPC158866
0.8792 High Similarity NPC85131
0.8792 High Similarity NPC295036
0.8786 High Similarity NPC203817
0.8784 High Similarity NPC105415
0.8784 High Similarity NPC470359

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC277426 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9214 High Similarity NPD970 Clinical (unspecified phase)
0.8836 High Similarity NPD2532 Approved
0.8836 High Similarity NPD2533 Approved
0.8836 High Similarity NPD2534 Approved
0.8618 High Similarity NPD7819 Suspended
0.8514 High Similarity NPD6799 Approved
0.8497 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8452 Intermediate Similarity NPD7075 Discontinued
0.8431 Intermediate Similarity NPD1934 Approved
0.8421 Intermediate Similarity NPD4380 Phase 2
0.8377 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8356 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8356 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8354 Intermediate Similarity NPD6232 Discontinued
0.8345 Intermediate Similarity NPD1510 Phase 2
0.8323 Intermediate Similarity NPD3817 Phase 2
0.8322 Intermediate Similarity NPD1240 Approved
0.8312 Intermediate Similarity NPD6801 Discontinued
0.8311 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.8301 Intermediate Similarity NPD6599 Discontinued
0.8299 Intermediate Similarity NPD1549 Phase 2
0.8269 Intermediate Similarity NPD3882 Suspended
0.8267 Intermediate Similarity NPD1511 Approved
0.8264 Intermediate Similarity NPD230 Phase 1
0.8258 Intermediate Similarity NPD2801 Approved
0.8217 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8212 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8207 Intermediate Similarity NPD1607 Approved
0.8199 Intermediate Similarity NPD7473 Discontinued
0.8188 Intermediate Similarity NPD4628 Phase 3
0.8188 Intermediate Similarity NPD3750 Approved
0.8182 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.8163 Intermediate Similarity NPD2796 Approved
0.8163 Intermediate Similarity NPD2935 Discontinued
0.8163 Intermediate Similarity NPD1551 Phase 2
0.8158 Intermediate Similarity NPD1512 Approved
0.8153 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8137 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8137 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8137 Intermediate Similarity NPD6166 Phase 2
0.8129 Intermediate Similarity NPD7411 Suspended
0.8105 Intermediate Similarity NPD5403 Approved
0.8098 Intermediate Similarity NPD7054 Approved
0.8098 Intermediate Similarity NPD5844 Phase 1
0.8089 Intermediate Similarity NPD5402 Approved
0.8089 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8063 Intermediate Similarity NPD6959 Discontinued
0.8049 Intermediate Similarity NPD7074 Phase 3
0.8049 Intermediate Similarity NPD7472 Approved
0.8038 Intermediate Similarity NPD7768 Phase 2
0.8037 Intermediate Similarity NPD3818 Discontinued
0.8012 Intermediate Similarity NPD5710 Approved
0.8012 Intermediate Similarity NPD5711 Approved
0.8012 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD6797 Phase 2
0.7987 Intermediate Similarity NPD3749 Approved
0.7974 Intermediate Similarity NPD5401 Approved
0.7952 Intermediate Similarity NPD7251 Discontinued
0.7914 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7904 Intermediate Similarity NPD7808 Phase 3
0.7899 Intermediate Similarity NPD9545 Approved
0.7879 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7872 Intermediate Similarity NPD9717 Approved
0.7857 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7852 Intermediate Similarity NPD3748 Approved
0.7852 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7844 Intermediate Similarity NPD6559 Discontinued
0.7799 Intermediate Similarity NPD1465 Phase 2
0.777 Intermediate Similarity NPD447 Suspended
0.7763 Intermediate Similarity NPD2800 Approved
0.7763 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7754 Intermediate Similarity NPD9493 Approved
0.7746 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.773 Intermediate Similarity NPD7199 Phase 2
0.7718 Intermediate Similarity NPD6651 Approved
0.7712 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7708 Intermediate Similarity NPD1203 Approved
0.7703 Intermediate Similarity NPD943 Approved
0.7687 Intermediate Similarity NPD411 Approved
0.7679 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7676 Intermediate Similarity NPD422 Phase 1
0.7671 Intermediate Similarity NPD6832 Phase 2
0.7669 Intermediate Similarity NPD5494 Approved
0.7658 Intermediate Similarity NPD3226 Approved
0.7647 Intermediate Similarity NPD1243 Approved
0.7643 Intermediate Similarity NPD920 Approved
0.7628 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7625 Intermediate Similarity NPD37 Approved
0.7616 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7616 Intermediate Similarity NPD2799 Discontinued
0.7616 Intermediate Similarity NPD7033 Discontinued
0.7613 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7607 Intermediate Similarity NPD919 Approved
0.7607 Intermediate Similarity NPD6234 Discontinued
0.7593 Intermediate Similarity NPD4967 Phase 2
0.7593 Intermediate Similarity NPD4965 Approved
0.7593 Intermediate Similarity NPD4966 Approved
0.7574 Intermediate Similarity NPD5953 Discontinued
0.7566 Intermediate Similarity NPD6099 Approved
0.7566 Intermediate Similarity NPD6100 Approved
0.7547 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7535 Intermediate Similarity NPD4626 Approved
0.7533 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7532 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7532 Intermediate Similarity NPD2654 Approved
0.753 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD2346 Discontinued
0.75 Intermediate Similarity NPD1608 Approved
0.75 Intermediate Similarity NPD3751 Discontinued
0.75 Intermediate Similarity NPD9269 Phase 2
0.75 Intermediate Similarity NPD3027 Phase 3
0.7483 Intermediate Similarity NPD9494 Approved
0.747 Intermediate Similarity NPD3787 Discontinued
0.7467 Intermediate Similarity NPD4060 Phase 1
0.7465 Intermediate Similarity NPD5691 Approved
0.7456 Intermediate Similarity NPD7286 Phase 2
0.7452 Intermediate Similarity NPD7390 Discontinued
0.7452 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7451 Intermediate Similarity NPD5408 Approved
0.7451 Intermediate Similarity NPD5406 Approved
0.7451 Intermediate Similarity NPD5404 Approved
0.7451 Intermediate Similarity NPD5405 Approved
0.745 Intermediate Similarity NPD3764 Approved
0.7442 Intermediate Similarity NPD8313 Approved
0.7442 Intermediate Similarity NPD8312 Approved
0.7436 Intermediate Similarity NPD6190 Approved
0.7429 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7419 Intermediate Similarity NPD1652 Phase 2
0.7417 Intermediate Similarity NPD6355 Discontinued
0.7417 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7417 Intermediate Similarity NPD5124 Phase 1
0.7415 Intermediate Similarity NPD1019 Discontinued
0.7413 Intermediate Similarity NPD1778 Approved
0.7403 Intermediate Similarity NPD2344 Approved
0.7396 Intermediate Similarity NPD7228 Approved
0.7384 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7375 Intermediate Similarity NPD1653 Approved
0.7365 Intermediate Similarity NPD7229 Phase 3
0.7358 Intermediate Similarity NPD6273 Approved
0.7351 Intermediate Similarity NPD1613 Approved
0.7351 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7347 Intermediate Similarity NPD2797 Approved
0.7343 Intermediate Similarity NPD9268 Approved
0.7333 Intermediate Similarity NPD3268 Approved
0.7333 Intermediate Similarity NPD1699 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD6798 Discontinued
0.7322 Intermediate Similarity NPD7435 Discontinued
0.7321 Intermediate Similarity NPD3926 Phase 2
0.7317 Intermediate Similarity NPD5353 Approved
0.7317 Intermediate Similarity NPD4288 Approved
0.7315 Intermediate Similarity NPD4908 Phase 1
0.7314 Intermediate Similarity NPD8150 Discontinued
0.7312 Intermediate Similarity NPD8151 Discontinued
0.7297 Intermediate Similarity NPD2798 Approved
0.7297 Intermediate Similarity NPD5647 Approved
0.7292 Intermediate Similarity NPD17 Approved
0.729 Intermediate Similarity NPD6002 Phase 3
0.729 Intermediate Similarity NPD6004 Phase 3
0.729 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.729 Intermediate Similarity NPD6005 Phase 3
0.729 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7279 Intermediate Similarity NPD1283 Approved
0.7278 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7261 Intermediate Similarity NPD7003 Approved
0.7255 Intermediate Similarity NPD6653 Approved
0.7253 Intermediate Similarity NPD6779 Approved
0.7253 Intermediate Similarity NPD6780 Approved
0.7253 Intermediate Similarity NPD6781 Approved
0.7253 Intermediate Similarity NPD6776 Approved
0.7253 Intermediate Similarity NPD6777 Approved
0.7253 Intermediate Similarity NPD6778 Approved
0.7253 Intermediate Similarity NPD6782 Approved
0.7241 Intermediate Similarity NPD3496 Discontinued
0.7226 Intermediate Similarity NPD2438 Suspended
0.7225 Intermediate Similarity NPD7685 Pre-registration
0.7222 Intermediate Similarity NPD7458 Discontinued
0.7219 Intermediate Similarity NPD5242 Approved
0.7219 Intermediate Similarity NPD1296 Phase 2
0.7219 Intermediate Similarity NPD2313 Discontinued
0.7219 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7216 Intermediate Similarity NPD8434 Phase 2
0.7215 Intermediate Similarity NPD2309 Approved
0.7202 Intermediate Similarity NPD1247 Approved
0.7192 Intermediate Similarity NPD1201 Approved
0.7192 Intermediate Similarity NPD1610 Phase 2
0.719 Intermediate Similarity NPD1933 Approved
0.7181 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7179 Intermediate Similarity NPD5762 Approved
0.7179 Intermediate Similarity NPD5763 Approved
0.7174 Intermediate Similarity NPD74 Approved
0.7174 Intermediate Similarity NPD9266 Approved
0.7171 Intermediate Similarity NPD6233 Phase 2
0.7162 Intermediate Similarity NPD3225 Approved
0.7161 Intermediate Similarity NPD4308 Phase 3
0.7159 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7153 Intermediate Similarity NPD1548 Phase 1
0.7152 Intermediate Similarity NPD4625 Phase 3
0.7143 Intermediate Similarity NPD7783 Phase 2
0.7143 Intermediate Similarity NPD7782 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data